Revenue Cycle Management Market Size, Share & Forecast 2026-2032
The only published RCM automation figure is 29x Waystar's entire revenue. What the US administrative cost base says about every number in this market.
$73.6B
$148.4B
12.4%
Global
Executive Summary
The headline finding of this report is a negative one: no defensible standalone market size for revenue cycle management automation exists in the public literature, and the one automation-specific figure we found fails arithmetic that a reader can run in thirty seconds.
MarketsandMarkets carries an explicit AI-versus-non-AI technology segmentation inside its whole-market RCM report and does not publish the split. The only automation-specific estimate available is Towards Healthcare's AI in healthcare revenue cycle management at $20.68 billion for 2024 growing at 24.20%. Advance that to 2026 and it is $31.90 billion. Waystar is the largest listed pure-play revenue cycle software company; its fiscal 2025 revenue was $1,099 million, counting every product it sells, automated or not. The published automation market is 29.0 times the entire revenue of the biggest vendor in the category. Add R1 RCM's last reported guidance of $2.625 to $2.675 billion before it went private and the two largest visible participants together are under $4 billion. A $31.9 billion automation market would require roughly eight more R1s and twenty more Waystars that nobody has heard of.
Whole-market RCM estimates are no better behaved, only better bounded. Base-year values for 2024 and 2025 run from $58.27 billion to $156.68 billion, a 2.69x spread, and 2030 forecasts from $117.50 billion to $658.7 billion, a 5.6x spread, while published growth rates agree closely at 11.39% to 13.2%. Arizton makes the contradiction explicit by publishing a United States-only market of $141.61 billion for 2024 -- 2.4 times another house's whole global market for the following year.
The scope decision is the familiar one in services markets. Providers run most of their revenue cycle with their own staff. A house that counts the internal cost of billing departments lands in the hundreds of billions; a house that counts vendor licences and outsourcing contracts lands in the tens. The Peterson-KFF Health System Tracker puts administrative expenses at 7.0% of 2024 national health expenditures, which is about $369.5 billion -- everything administrative in US healthcare, payer overhead and underwriting margin included. Grand View Research's $658.7 billion global RCM market for 2030 is 1.78 times that entire base. It is not a coherent figure.
Key Highlights
No defensible standalone size for RCM automation exists: the one automation-specific estimate, advanced to 2026, is $31.90 billion against Waystar's entire $1,099 million fiscal 2025 revenue -- a ratio of 29.0x
The two largest visible vendors, Waystar at $1,099 million and R1 RCM at a last-guided $2.625 to $2.675 billion, total under $4 billion
Whole-market base-year values spread 2.69x and 2030 forecasts 5.6x ($117.50 billion to $658.7 billion), while published CAGRs agree at 11.39% to 13.2%
Administrative expenses were 7.0% of 2024 US national health expenditures, about $369.5 billion -- and the highest published global forecast is 1.78 times that entire base
Arizton's United States-only market of $141.61 billion for 2024 is 2.2 times MarketsandMarkets' whole global market for 2025
The headline published here is 2.68% of the $2,744.4 billion of 2024 US hospital and physician billings, below the 4% to 8% of collections that outsourcing contracts typically carry
MarketsandMarkets names AI-based solutions the fastest-growing technology segment in this market and does not publish its value
Market Overview
Market Context
Revenue cycle management exists because American healthcare bills in a way that requires an industry to interpret. National health expenditures reached $5.3 trillion in 2024, with hospital care at $1,634.7 billion and physician and clinical services at $1,109.7 billion -- $2,744.4 billion of billed provider activity, every unit of which has to be coded, authorised, submitted, adjudicated, appealed and collected. The Peterson-KFF Health System Tracker puts total administrative expenses at 7.0% of national health expenditures in 2024, down from 7.5% in 2023 and a peak of 8.4% in 2020, which is about $369.5 billion. That $369.5 billion is the ceiling on everything this market could ever address, and most of it is not addressable at all: it includes payer overhead, government programme administration, taxes, fees and underwriting gains and losses. CMS renamed the relevant national accounts line from 'Net Cost of Health Insurance' to the 'Health Insurance Non-Medical Ratio' in its 2024 comprehensive revision, which is a useful reminder that the administrative accounts were not built to answer vendor questions. What is addressable is the slice providers choose to buy rather than staff. Against 6,100 US hospitals, 5,121 of them community hospitals, and the far larger population of physician practices, the vendor market that has actually emerged is small and concentrated. Waystar, the largest listed pure-play, booked $1,099 million in fiscal 2025, up 17% and 13% organically, split $558.4 million subscription and $534.8 million volume-based, and guided 2026 to $1.274 to $1.294 billion. R1 RCM, the largest outsourcer, guided fiscal 2024 to $2.625 to $2.675 billion with adjusted EBITDA of $650 to $670 million and then went private, since when it reports nothing. Ensemble Health Partners is private and discloses no financials -- the only public figure we could find was a commercial database's unaudited $100 to 500 million range, which that database itself describes as a statistical evaluation. A market whose visible participants total under $4 billion is not a $658 billion market. It is a function that mostly runs on salaried staff, with a vendor layer attached.
No defensible standalone size for revenue cycle management automation exists: the only automation-specific published figure, advanced to 2026, is $31.90 billion, which is 29.0 times the $1,099 million total fiscal 2025 revenue of Waystar, the largest listed pure-play RCM software vendor. This report therefore publishes whole-market RCM with automation as the growth vector: $73.61 billion in 2026 to $148.44 billion by 2032 at 12.4%, on the one scope that states an AI-versus-non-AI segmentation. Published base-year values spread 2.69x and 2030 forecasts 5.6x, while growth rates agree at 11.39% to 13.2%. The high estimates exceed the entire $369.5 billion administrative cost of US healthcare.
Market Stage
Growth
Adoption Level
Universal as a function; mostly staffed in-house, with automation adoption early and unmeasured
Key Trends
Market Forecast & Data
Base Year (2026)
$73.6B
Forecast (2032)
$148.4B
CAGR (2026-2032)
12.4%
| Year | Market size ($ Billion) |
|---|---|
| 2026Base year | $73.61B |
| 2027 | $82.74B |
| 2028 | $93.00B |
| 2029 | $104.53B |
| 2030 | $117.49B |
| 2031 | $132.06B |
| 2032 | $148.44B |
The curve shown here is modelled at a constant 12.4% rate. MarketsandMarkets publishes $58.27 billion for 2024, $65.49 billion for 2025 and $117.50 billion for 2030 at a stated 12.4% CAGR, and those endpoints are internally consistent: $65.49 billion to $117.50 billion over five years implies 12.40% exactly. The 2026 base of $73.61 billion is the published 2025 value advanced one year at that rate, and the 2032 endpoint of $148.44 billion continues it. The intermediate years are interpolation, not separately sourced observations. This series was chosen because it is the only house that states an AI-versus-non-AI technology segmentation inside a scope that names what it counts -- front-end, mid-cycle and back-end products plus outsourcing services -- it is arithmetically consistent with itself, and it is the only series that survives the grounding tests. Advanced to 2026 it is 2.68% of US hospital and physician billings, an upper bound because it places a global numerator over a US-only denominator, and below the 4% to 8% of collections that RCM outsourcing contracts typically carry. That is consistent with most providers still running the function in-house. We publish this as whole-market RCM with automation as the growth vector, and we say so rather than publishing an automation headline we cannot defend. That is the finding. MarketsandMarkets itself identifies AI-based solutions as the fastest-growing technology segment within the market and does not publish its value. Towards Healthcare does publish a value, and it is 29 times the revenue of the largest vendor in the category. Readers who need an automation-only figure should treat this report's headline as the envelope that figure has to fit inside, not as a substitute for it. The honest statement is that automation is the fastest-growing part of a market of roughly $74 billion in 2026, and that nobody has sized it in a way that survives division by Waystar's income statement.
Market Dynamics
- The sheer volume of billed activity requiring administration: $1,634.7 billion of hospital care and $1,109.7 billion of physician and clinical services in the United States in 2024, every unit of which must be coded, authorised, submitted and collected
- Administrative cost pressure with a visible trend: administrative expenses fell from a 2020 peak of 8.4% of national health expenditures to 7.0% in 2024, which is the efficiency gain automation is sold to extend
- Denials and prior authorisation volume, which MarketsandMarkets and Towards Healthcare both name as the leading automation application and which grows with payer utilisation management rather than with patient volume
- Labour scarcity and wage inflation in billing and coding roles, which changes the build-versus-buy calculation for providers who have always staffed the function
- Outsourcing growth running ahead of software: syndicated segment rates put outsourcing services at a 12.5% CAGR against 10.5% for the solutions component
Market Segmentation
By Type
- Front-end products: scheduling, registration, eligibility and benefits verification, prior authorisation
- Mid-cycle products: clinical documentation, coding, charge capture
- Back-end products: claims submission, denials and appeals, payment posting, patient collections
- Outsourced revenue cycle services
- Integrated AI and automation platforms
- Standalone automation tools
By End User
- Hospitals and health systems
- Physician practices and ambulatory groups
- Ambulatory surgery centres
- Diagnostic laboratories and imaging centres
- Post-acute and behavioural health providers
- Revenue cycle outsourcing firms
By Application
- Claims and denials management
- Eligibility and benefits verification
- Prior authorisation
- Medical coding and clinical documentation integrity
- Patient financial engagement and collections
- Contract and underpayment analytics
Competitive Landscape
Waystar
United States
Reported fiscal 2025 revenue of $1,099 million on 17 February 2026, up 17% year on year and 13% organically, split $558.4 million subscription (up 22%) and $534.8 million volume-based (up 11%), with fourth-quarter revenue of $304 million up 24% and 12% organic, and 2026 guidance of $1.274 to $1.294 billion. Waystar reports subscription against volume-based revenue, not automated against manual, so its automation revenue is not disclosed. The comparison that matters is arithmetic rather than share: the only published automation-specific market size, advanced to 2026, is $31.90 billion, which is 29.0 times this company's entire revenue -- our own division of a published market estimate by a reported revenue figure, stated as arithmetic and not as a market share.
R1 RCM
United States
Guided fiscal 2024 revenue to $2.625 to $2.675 billion with GAAP operating income of $105 to $135 million and adjusted EBITDA of $650 to $670 million. The company was taken private in 2024 and no longer reports, so that guidance is the last public figure and it is guidance rather than a reported result. Its model is predominantly staffed service delivery with technology attached, which is the structural reason the outsourcing half of this market is larger than the software half. No share figure is disclosed or computable.
Ensemble Health Partners
United States
Named best company for end-to-end revenue cycle outsourcing in 2024 by KLAS Research. Privately held and publishes no financials; the only public revenue indication we could find is a commercial database's unaudited $100 to 500 million range, which that database itself describes as a statistical evaluation of a private company and which we therefore do not use. No size or share figure exists for it.
Optum
United States
Runs revenue cycle services at national scale for hospital and physician clients alongside its payer-side businesses. Reported within UnitedHealth Group's Optum segments with no revenue cycle line item, so neither its revenue nor its share in this market can be stated. Its ownership structure is itself a market dynamic, since provider clients are contracting administration to a business affiliated with a payer.
Epic Systems
United States
Sells revenue cycle functionality as modules of the electronic health record rather than as a separate product, which makes it a default rather than a purchase for much of the US hospital market. Privately held and files no financial statements; revenue has been press-reported at about $6.7 billion for 2025 on a whole-company basis, with no revenue cycle breakout. Its position is the main reason the software half of this market grows more slowly than the outsourcing half.
Oracle Health
United States
Supplies revenue cycle functionality alongside its electronic health record to hospital clients. Consolidated inside Oracle with no revenue cycle segment, so no size or share figure exists for it in this market.
Recent Developments
Reported fourth quarter and fiscal year 2025 results on 17 February 2026: full-year revenue of $1,099 million, up 17% and 13% organically, with subscription revenue of $558.4 million up 22% and volume-based revenue of $534.8 million up 11%; fourth-quarter revenue of $304 million, up 24% with 12% organic growth; and 2026 revenue guidance of $1.274 to $1.294 billion.
Released the 2024 National Health Expenditure accounts in January 2026: national health spending grew 7.2% to $5.3 trillion, or $15,474 per person and 18.0% of GDP, with hospital care at $1,634.7 billion and physician and clinical services at $1,109.7 billion. The accompanying Health Affairs analysis recorded Medicaid government administration costs rising 19.8% in 2024 against 9.2% in 2023, attributed to continued Medicaid unwinding operations.
Updated its AI in healthcare revenue cycle management sizing on 21 April 2026, publishing $20.68 billion for 2024, $25.7 billion for 2025 and $180.33 billion for 2034 at a 24.20% CAGR, with a stated scope of using artificial intelligence to automate and improve billing, coding, claims processing and payment tasks. The page states the CAGR period inconsistently, giving 2024-2034 in its overview and 2025-2034 in its metrics table.
In the 2024 comprehensive revision to the National Health Expenditure Accounts, renamed the 'Net Cost of Health Insurance' measure the 'Health Insurance Non-Medical Ratio', which continues to represent administrative costs, taxes, fees and underwriting gains and losses as a share of total private health insurance expenditures.
Regulatory Landscape
Research Methodology
Primary research
- No primary interviews were conducted for this edition. This report is a synthesis of government statistics, public filings and published third-party estimates, and is labelled as such rather than implying fieldwork that did not occur.
Secondary research
- Centers for Medicare & Medicaid Services, National Health Expenditure Fact Sheet (2024 data, released January 2026): NHE $5.3 trillion in 2024, up 7.2%, $15,474 per person, 18.0% of GDP; hospital care $1,634.7 billion; physician and clinical services $1,109.7 billion
- Peterson-KFF Health System Tracker: administrative expenses were 7.0% of total national health expenditures in 2024, down from 7.5% in 2023 and a peak of 8.4% in 2020
- Health Affairs, 'National Health Care Spending Increased 7.2 Percent In 2024 As Utilization Remained Elevated': 2024 national health expenditures of $5,278.6 billion; Medicaid government administration costs up 19.8% in 2024 against 9.2% in 2023
- CMS, 'Summary of the 2024 Comprehensive Revision to the National Health Expenditure Accounts': the 'Net Cost of Health Insurance' measure renamed the 'Health Insurance Non-Medical Ratio', continuing to represent administrative costs, taxes, fees and underwriting gains and losses as a share of total private health insurance expenditures
- American Hospital Association, Fast Facts on U.S. Hospitals, 2024 AHA Annual Survey: 6,100 hospitals, 5,121 community hospitals, 907,216 staffed beds, 35,658,583 admissions
- Waystar Holding Corp., fourth quarter and fiscal year 2025 results, 17 February 2026: revenue $1,099 million up 17% and 13% organic; subscription $558.4 million up 22%; volume-based $534.8 million up 11%; Q4 $304 million up 24%; 2026 guidance $1.274 to $1.294 billion
- R1 RCM fiscal 2024 guidance of $2.625 to $2.675 billion revenue, $105 to $135 million GAAP operating income and $650 to $670 million adjusted EBITDA, reported by TipRanks/The Fly -- guidance rather than a reported result, and the company has since been taken private and no longer reports
- MarketsandMarkets, revenue cycle management market, report 153900104: $58.27 billion (2024), $65.49 billion (2025), $117.50 billion (2030), 12.4% CAGR, with front-end, mid-cycle and back-end products plus outsourcing services and a separate AI versus non-AI technology segmentation naming AI-based solutions as the fastest-growing technology segment
- Towards Healthcare, AI in healthcare revenue cycle management market sizing, last updated 21 April 2026: $20.68 billion (2024), $25.7 billion (2025), $180.33 billion (2034), 24.20% CAGR, scope stated as using artificial intelligence to automate and improve billing, coding, claims processing and payment tasks
- Allied Market Research ($109.53 billion 2021 to $367.7 billion 2031 at 13.2%), Global Market Insights April 2023 edition ($141.2 billion 2022 to $489.2 billion 2032 at 12.8%), Precedence Research ($135.12 billion by 2027 at 12.5%), Arizton United States-only ($141.61 billion 2024 to $272.78 billion 2030 at 11.55%), a GII-syndicated report ($156.68 billion 2024 to $343.12 billion 2031 at 11.8%, with solutions at 10.5% and outsourcing services at 12.5%), Ken Research (about $201 billion by 2030) and Grand View Research ($658.7 billion by 2030 at 11.39%, reached only through third-party reposts and flagged as unverified)
Validation: Market size is taken from published third-party estimates and attributed to each house by name; no methodology behind those estimates was inspected, and they are presented as published estimates rather than as verified measurements. Three plausibility tests were run against government statistics and reported company revenue. First, administrative expenses were 7.0% of 2024 national health expenditures of $5,278.6 billion, about $369.5 billion, which is everything administrative in US healthcare including payer overhead and underwriting margin; Grand View Research's $658.7 billion global RCM market for 2030 is 1.78 times that entire base and is therefore ruled out, as are the published figures approaching it. Second, the headline published here advanced to 2026, $73.61 billion, is 2.68% of the $2,744.4 billion of 2024 US hospital and physician billings -- an upper bound because it places a global numerator over a US-only denominator -- which sits below the 4% to 8% of collections that RCM outsourcing contracts typically carry and is consistent with most providers running the function in-house. Third, the only automation-specific published estimate, advanced to 2026 at its own stated rate, is $31.90 billion, which is 29.0 times Waystar's entire reported fiscal 2025 revenue of $1,099 million; adding R1 RCM's last guided $2.625 to $2.675 billion, the two largest visible participants total under $4 billion, so that automation figure is ruled out as vendor revenue and this report publishes whole-market RCM instead, with automation identified as the growth vector and explicitly not sized. None of these tests establishes the correct market size and none is offered as an estimate; each is a division of two differently scoped published numbers and is labelled as such. The 2026 base and 2032 endpoint are MarketsandMarkets' published 2025 value advanced at its published 12.4% rate, not separately published observations. One figure was deliberately not used: the exact 2024 government administration line from the CMS national accounts, because the CMS highlights PDF would not extract and the only value located, $66.1 billion, came from a Health Affairs projections paper rather than final historical tables.
Strategic Takeaways
the one that exists is 29 times the revenue of the largest vendor in the category
divide any global RCM forecast by about $369.5 billion and reject anything that exceeds the entire administrative spend of the world's most administratively expensive health system
a United States-only figure larger than another house's global figure means at least one of them is counting the function's cost rather than vendors' revenue
2% to 3% of collections is where the vendor layer actually sits, and 4% to 8% is what a full outsourcing contract costs
the better these products work, the more pricing pressure follows, which is why a 24% automation CAGR and a 12% market CAGR cannot both be describing vendor revenue
Frequently Asked Questions
Related research
Reports in the same field, each with its base-year figure and the growth rate it is published at.
- Healthcare ITFertility Services Market$58.2B · 12.15% CAGR
- Healthcare ITGlobal Telemedicine Industry Size, Competitive Landscape and Regional Analysis$111.0B · 11.7% CAGR
- Healthcare ITGlobal Remote Patient Monitoring Market$26.0B · 19.9% CAGR
- Healthcare ITGlobal Mental Health Technology Industry Size, Competitive Landscape and Regional Analysis$24.8B · 18.7% CAGR
- Healthcare ITGlobal Healthcare AI Market$13.4B · 34% CAGR
- Healthcare ITDecentralized Clinical Trials Market$10.2B · 13% CAGR